Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTCMKTS · Delayed Price · Currency is USD
5.00
0.00 (0.00%)
Nov 17, 2025, 4:00 PM EST
HNSPF Revenue
Hansoh Pharmaceutical Group Company had revenue of 7.43B CNY in the half year ending June 30, 2025, with 64.78% growth. This brings the company's revenue in the last twelve months to 13.19B, up 9.02% year-over-year. In the year 2024, Hansoh Pharmaceutical Group Company had annual revenue of 12.26B with 21.35% growth.
Revenue (ttm)
13.19B CNY
Revenue Growth
+9.02%
P/S Ratio
16.66
Revenue / Employee
1.47M CNY
Employees
8,989
Market Cap
30.67B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.26B | 2.16B | 21.35% |
| Dec 31, 2023 | 10.10B | 721.40M | 7.69% |
| Dec 31, 2022 | 9.38B | -552.73M | -5.56% |
| Dec 31, 2021 | 9.94B | 1.24B | 14.33% |
| Dec 31, 2020 | 8.69B | 7.49M | 0.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 105.45M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| China New Energy Group Co. | 12.51M |
| Nuo Therapeutics | 2.61M |